WHO approves clinical trials on two new Ebola vaccines
AI Executive Briefing
Verified Synthesis~32s readThe Nigeria Centre for Disease Control and Prevention confirmed the case in the Federal Capital Territory on October 20, involving a woman who had travelled from Uganda. File photo: Health workers in Ebola kits The World Health Organisation on Wednesday approved clinical trials for two new Ebola vaccines, as doctors fight to control an outbreak in Africa that has killed more than 5,300 people.
Context & Background
- ✦“Last month, a vaccine trial began using the Ervebo vaccine, which is approved for Ebola virus, but not for Bundibugyo virus” ravaging the Democratic Republic of Congo, WHO chief Tedros Adhanom Ghebreyesus told reporters.
Key Figures & Named Entities
Wednesday:File photo: Health workers in Ebola kits The World Health Organisation on Wednesday approved clinical trials for two new Ebola vaccines, as doctors fight to control an outbreak in Africa that has killed more than 5,300 people.Today:“Today, WHO expert groups are recommending adding two vaccine candidates to the trial” he added.Monday:On Monday, the Africa Centres for Disease Control and Prevention (Africa CDC) said Africa’s ongoing Ebola epidemic had killed more than 5,300 people, the vast majority of them in the Democratic Republic of Congo.
Outlook & Next Steps
Follow original publisher reporting for subsequent developments, official responses, and verified updates.
Key Takeaways
Verified Extract- The Nigeria Centre for Disease Control and Prevention confirmed the case in the Federal Capital Territory on October 20, involving a woman who had travelled from Uganda.
- File photo: Health workers in Ebola kits The World Health Organisation on Wednesday approved clinical trials for two new Ebola vaccines, as doctors fight to control an outbreak in Africa that has killed more than 5,300 people.
- “Last month, a vaccine trial began using the Ervebo vaccine, which is approved for Ebola virus, but not for Bundibugyo virus” ravaging the Democratic Republic of Congo, WHO chief Tedros Adhanom Ghebreyesus told reporters.
Key Facts:Wednesday: File photo: Health workers in Ebola kits The World Health Organisation on Wednesday approved clinical trials for two new Ebola vaccines, as doctors fight to control an outbreak in Africa that has killed more than 5,300 people.Today: “Today, WHO expert groups are recommending adding two vaccine candidates to the trial” he added.Monday: On Monday, the Africa Centres for Disease Control and Prevention (Africa CDC) said Africa’s ongoing Ebola epidemic had killed more than 5,300 people, the vast majority of them in the Democratic Republic of Congo.2026: The laboratory confirmation on October 20 made Nigeria the fifth country to detect the virus since the outbreak was declared in the Democratic Republic of the Congo on May 15, 2026.
Editorial Excerpt
The World Health Organisation has approved clinical trials for two new Ebola vaccines to combat the Bundibugyo virus strain amid an outbreak in Africa.
Frequently Asked Questions About This Story
What is the latest development regarding Federal Capital Territory?
The Nigeria Centre for Disease Control and Prevention confirmed the case in the Federal Capital Territory on October 20, involving a woman who had travelled from Uganda.
Who are the key organizations or public figures mentioned?
The primary parties identified in this coverage include Federal Capital Territory, Nigeria Centre for Disease Control, Port Harcourt.
What timeline or key figures were confirmed?
File photo: Health workers in Ebola kits The World Health Organisation on Wednesday approved clinical trials for two new Ebola vaccines, as doctors fight to control an outbreak in Africa that has killed more than 5,300 people.
